Novolog Mix 70/30 PenFill Interactions
There are 392 drugs known to interact with Novolog Mix 70/30 PenFill (insulin aspart/insulin aspart protamine), along with 3 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 15 are major, 356 are moderate, and 21 are minor.
- View all 392 medications that may interact with Novolog Mix 70/30 PenFill
- View Novolog Mix 70/30 PenFill alcohol/food interactions (2)
- View Novolog Mix 70/30 PenFill disease interactions (3)
Most frequently checked interactions
View interaction reports for Novolog Mix 70/30 PenFill (insulin aspart/insulin aspart protamine) and the medicines listed below.
- acetaminophen / hydrocodone
- Advair Diskus (fluticasone / salmeterol)
- Aggrenox (aspirin / dipyridamole)
- albuterol
- Aldurazyme (laronidase)
- Alimta (pemetrexed)
- alprazolam
- amoxicillin
- Aptivus (tipranavir)
- Aranesp (darbepoetin alfa)
- atorvastatin
- Avastin (bevacizumab)
- azithromycin
- Baraclude (entecavir)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- Brineura (cerliponase alfa)
- Bystolic (nebivolol)
- Celebrex (celecoxib)
- Crestor (rosuvastatin)
- Cymbalta (duloxetine)
- Dilaudid (hydromorphone)
- furosemide
- glimepiride
- Lasix (furosemide)
- Levemir (insulin detemir)
- levothyroxine
- metformin
- oxygen
- Synthroid (levothyroxine)
Novolog Mix 70/30 PenFill alcohol/food interactions
There are 2 alcohol/food interactions with Novolog Mix 70/30 PenFill (insulin aspart/insulin aspart protamine).
Novolog Mix 70/30 PenFill disease interactions
There are 3 disease interactions with Novolog Mix 70/30 PenFill (insulin aspart/insulin aspart protamine) which include:
Report options
More about Novolog Mix 70/30 PenFill (insulin aspart/insulin aspart protamine)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.